A few days ago, the National Medical Insurance Administration issued a notice requiring all provinces to temporarily incorporate the new coronavirus antigen detection reagents and corresponding detection items into the catalogue of basic medical insurance medical service items according to procedures; It is temporarily included in the payment scope of the medical insurance fund. For the newly added naimatevir tablets/ritonavir tablets, the medical institutions shall purchase them according to the price agreed by the enterprise and the relevant departments, and the medical insurance department shall pay according to the regulations.
The new crown antigen test is included in the medical insurance, which reflects the scientific and precise concept of prevention and control.
As a supplementary method for nucleic acid testing, antigen testing has a low technical threshold. It is not only easy to carry out in grass-roots units and communities, but also people can self-check at home. Compared with nucleic acid testing, antigen testing is fast and easy to operate, which can effectively improve "early detection". "Ability.
Temporary inclusion of COVID-19 antigen detection products in medical insurance can fully motivate relevant groups to "test as much as they should", facilitate rapid screening and triage management, and effectively reduce runs on medical resources. big account.
At the same time, the ability of rapid virus detection will be greatly improved, and the epidemic prevention and control network will be more firmly woven, which can also play an important role in adjusting and improving my country's existing epidemic prevention and control strategies.
The inclusion of new coronavirus treatment drugs into the scope of medical insurance reimbursement demonstrates the responsibility of "people first, life first".
Nematicavir Tablets/Ritonavir Tablets are oral small-molecule new coronavirus treatment drugs, which can be used to treat adult patients with mild to moderate new coronavirus pneumonia with high risk factors for progression to severe disease.
The Omicron variant is extremely contagious, and the earlier the antiviral treatment is in the patient's treatment process, the better the effect.
Controlling virus replication at an early stage, minimizing the risk of infection, and providing a bottom-line guarantee for early treatment are measures that are practically considered by the people in light of the new situation and new circumstances.
It is believed that with the support of the medical insurance department, the medical treatment of the new crown will be further improved, and the people's health rights and interests will be further protected.
(Author: Wu Jiajia)